Sign in

CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811567056
Phone
206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy SVP Operations, CMO bought 25,000 shares at $0.76 ($19,000)
  13. 4 Open-market buy Director bought 100,000 shares at $0.76 ($75,520)
  14. 4 Open-market buy Board of Directors bought 55,015 shares at $0.83 ($45,861)
  15. 4 Open-market buy Board of Directors bought 10,000 shares at $0.90 ($8,996)
  16. 4 Open-market buy Board of Directors bought 30,000 shares at $0.89 ($26,601)
  17. 4 Open-market buy Board of Directors bought 26,460 shares at $0.90 ($23,740)
  18. 4 Open-market buy Board of Directors bought 14,404 shares at $0.87 ($12,596)
  19. 4 Open-market buy Board of Directors bought 19,136 shares at $0.87 ($16,704)
  20. 4 Open-market buy Board of Directors bought 11,375 shares at $0.85 ($9,662)

Page 8 of 14 · 265 filings